| Title : The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease - Serrano_2017_J.Psychiatry.Neurosci_42_59 |
| Author(s) : Serrano MP , Herrero-Labrador R , Futch HS , Serrano J , Romero A , Fernandez AP , Samadi A , Unzeta M , Marco-Contelles J , Martinez-Murillo R |
| Ref : J Psychiatry Neurosci , 42 :59 , 2017 |
| Abstract : Serrano_2017_J.Psychiatry.Neurosci_42_59 |
| ESTHER : Serrano_2017_J.Psychiatry.Neurosci_42_59 |
| PubMedSearch : Serrano_2017_J.Psychiatry.Neurosci_42_59 |
| PubMedID: 27636528 |
Serrano MP, Herrero-Labrador R, Futch HS, Serrano J, Romero A, Fernandez AP, Samadi A, Unzeta M, Marco-Contelles J, Martinez-Murillo R (2017)
The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease
J Psychiatry Neurosci
42 :59
Serrano MP, Herrero-Labrador R, Futch HS, Serrano J, Romero A, Fernandez AP, Samadi A, Unzeta M, Marco-Contelles J, Martinez-Murillo R (2017)
J Psychiatry Neurosci
42 :59